Business Wire Feed
Celltrion receives Health Canada approval for Eydenzelt®, a biosimilar referencing Eylea® (aflibercept 2mg)
Eydenzelt® a biosimilar referencing Eylea®, receives a Notice of Compliance from Health Canada (aflibercept 2mg) The approval is based on the totality of evidence, including analytical, nonclinical, and clinical data from global Phase III studies more...
Kayla’s Children Centre Announces Camp Lionheart
A New Fully Accessible, Year-Round Camp for Children with Disabilities. TORONTO--(BUSINESS WIRE)--Kayla’s Children Centre (KCC), a Thornhill-based non-profit organization dedicated to supporting children with disabilities and medical complexities, today announced the creation of Camp Lionheart, more...
AHF Warns in New Lancet HIV Letter That Current HIV Testing Rules May Delay Treatment
LOS ANGELES--(BUSINESS WIRE)--A new Correspondence Letter in The Lancet HIV from AIDS Healthcare Foundation (AHF) raises concerns that the World Health Organization’s recommended three-test system for HIV diagnosis—designed to avoid rare false-positive results—may unintentionally slow more...
AHF: Ghana and DRC Presidents Call for Regional Health Leadership and Sustainable Financing in Africa at AIDS Conference (ICASA 2025)
ACCRA, Ghana--(BUSINESS WIRE)--#Africa--The AIDS Healthcare Foundation (AHF) Global Public Health Institute, in collaboration with The Society for AIDS in Africa (SAA), will host a High-Level Summit on Regional Health Leadership and Sustainable Financing in Africa more...
SFI Health™ Reports Promising Results From a Preliminary Study Evaluating the Impact of Long-Chain Polyunsaturated Fatty Acids on Reading and Writing Skills in Children
- The study sponsored by La Nostra Famiglia highlights key brain processes that mediate the effects of omega-3s on literacy development - Further research into the biological mechanisms explaining the effects of omega-3 LCPUFAs on more...
Crux Emerges from Stealth with $6.5 Million in Funding, Launches First-Ever No-Cost Benefit to Make Popular Quality-of-Life Medications More Affordable
MCLEAN, Va.--(BUSINESS WIRE)--Crux, the first benefits platform partnering with big pharma and employers of all sizes to expand transparent and affordable access to transformative quality-of-life (QoL) medications, today announced its public launch with $6.5 million more...
a2z Radiology AI Introduces First Multi-Condition Triage for Abdomen-Pelvis CT
BOSTON--(BUSINESS WIRE)--a2z Radiology AI has received U.S. FDA clearance for a2z-Unified-Triage, a single device that flags and prioritizes seven urgent findings on abdomen-pelvis CT scans simultaneously. With RSNA 2025, radiology's largest annual conference, just days more...
My Mountain Mover Wins Big, Taking Home Three Awards at the 2025 Stevie Awards for Women in Business
NEW YORK--(BUSINESS WIRE)--#medicaloutsourcing--My Mountain Mover, a leading healthcare outsourcing company, has been named the winner of two Gold awards and one Silver award in the 2025 Stevie® Awards for Women in Business. The Stevie Awards more...
Zoetis Receives European Commission Marketing Authorization for Lenivia® (izenivetmab) to Reduce Pain Associated with Osteoarthritis (OA) in Dogs
PARSIPPANY, N.J.--(BUSINESS WIRE)--$ZTS #animalhealth--Zoetis Inc. today announced that the European Commission has granted the company marketing authorization for Lenivia® (izenivetmab) for the reduction of pain associated with osteoarthritis (OA) in dogs. Lenivia is a new more...
Feinstein Institutes secures $3.37M grant to strengthen first responder mental health and resilience
New research study aims to treat PTSD and depression, in collaboration with Stony Brook University and Texas A&M MANHASSET, N.Y.--(BUSINESS WIRE)--Recent reports show that one in seven first responders have probable post-traumatic stress disorder (PTSD) more...
Antibody Contract Development & Manufacturing Organization Market Report 2025-2033 – Rising Demand for Biologics Spurs Antibody CDMO Market Expansion, Growing at a 9.38% CAGR – ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "Antibody Contract Development & Manufacturing Organization Market Forecast to 2033" has been added to ResearchAndMarkets.com's offering. The global antibody contract development and manufacturing organization (CDMO) market is poised for substantial growth, with its more...
The Luskin Orthopaedic Institute for Children (LuskinOIC) Celebrates 25 Years of Holiday Food Basket Giveaway, Supporting Families Through Community Tradition
Annual Thanksgiving event brings together staff, volunteers, and community partners to provide customized food baskets to patients and families LOS ANGELES--(BUSINESS WIRE)--#Family--Luskin Orthopaedic Institute for Children (LuskinOIC) hosted its 25th Annual Holiday Food Basket Giveaway, more...
Cleerly Unveils PowerScribe Integration and Lesion-Level Reporting at RSNA 2025
New additions streamline data transfer with lesion details, helping make information more accessible for care teams DENVER--(BUSINESS WIRE)--#AI--Cleerly, a leader in AI-based cardiovascular imaging, will showcase new product updates at RSNA 2025, November 30 - more...
Galux Achieves Breakthrough by Delivering High-Affinity De Novo Antibodies from Only 50 AI Designs, Marking a New Era in Precision Protein Design
Achieving over 30% success rate with just 50 designs, this milestone demonstrates a clear shift from serendipitous antibody discovery to precision design SEOUL, South Korea--(BUSINESS WIRE)--#AI--Galux, a South Korean biotech pioneering AI-driven protein therapeutics more...
Vistagen Reports Findings on PH80’s Brain and Autonomic Effects in Women with Menopausal Hot Flashes at The Menopause Society 2025 Annual Meeting
Research supports the product candidate’s non-hormonal, non-systemic, rapidly-acting effects on autonomic biomarkers SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Vistagen (Nasdaq: VTGN), a late clinical-stage biopharmaceutical company pioneering neuroscience with nose-to-brain neurocircuitry to develop and commercialize a new more...
Public Health Workers Hold Media Briefing as Syphilis Spreads, Water Systems Go Untested, and Public Health Units Cut Services
TORONTO--(BUSINESS WIRE)--Following months of mergers and years of cuts, CUPE public health workers will hold a media briefing on the state of sexual health, communicable diseases, and waterborne illnesses in the province. The briefing will more...
GE HealthCare unveils Pristina Recon DL for mammography – deep learning image reconstruction technology delivering clearer image quality
GE HealthCare has received FDA Premarket Authorization for Pristina Recon DL, an innovative 3D mammography reconstruction application. Powered by artificial intelligence (AI), Pristina Recon DL delivers sharper images with fewer artifacts, enhanced details, and greater more...
AdvoCare Kicks Off the Holidays with its Black Friday Sale — 25% Off Sitewide
RICHARDSON, Texas--(BUSINESS WIRE)--#AdvoCareRehydrate--AdvoCare International, LLC continues its annual tradition of giving back with its latest sitewide discount. All products are 25% off at AdvoCare.com on Black Friday. It’s the perfect opportunity to stock up on more...
DocGo Announces Participation at Upcoming December Investor Conferences
NEW YORK--(BUSINESS WIRE)--DocGo Inc. (Nasdaq: DCGO) (“DocGo”), a leading provider of technology-enabled mobile health and medical transportation services, announced today that management will be participating in the following investor conferences in December: Noble Capital Markets more...
Merck to Participate in the Citi 2025 Global Healthcare Conference
RAHWAY, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today that Chirfi Guindo, chief marketing officer, Human Health, and Dr. Eliav Barr, senior vice president, head of global more...
IMFINZI® approved in the US as first and only perioperative immunotherapy for patients with early gastric and gastroesophageal cancers
Based on MATTERHORN Phase III trial results which showed a 29% reduction in the risk of progression, recurrence or death and a 22% reduction in the risk of death for the IMFINZI regimen vs. chemotherapy more...
Novocure to Participate in 37th Annual Piper Sandler Healthcare Conference
BAAR, Switzerland--(BUSINESS WIRE)--Novocure (NASDAQ: NVCR) announced today that management will participate in the 37th Annual Piper Sandler Healthcare Conference in New York on Tuesday, December 2, 2025. William Doyle, Novocure’s Executive Chairman, will take part more...
Bristol Myers Squibb to Participate in Citi’s 2025 Global Healthcare Conference
PRINCETON, N.J.--(BUSINESS WIRE)--Bristol Myers Squibb (NYSE: BMY) today announced that the company will participate in Citi’s 2025 Global Healthcare Conference on Thursday, December 4, 2025. The company will take part in a fireside chat beginning more...
Merck to Participate in the 8th Annual Evercore ISI HealthCONx Conference
RAHWAY, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today that Chirfi Guindo, chief marketing officer, Human Health, and Dr. Eliav Barr, senior vice president, head of global more...
Micro-X Unveils Updated Rover Mobile X-ray System Ahead of International Debut at RSNA 2025
Lumen glass-free high-resolution panel, in-bin charging, larger touchscreen and enhanced usability — launching at Booth 6537 ADELAIDE, Australia--(BUSINESS WIRE)--Micro-X Limited (ASX: MX1), a global leader in miniaturised X-ray technology, will debut its updated Rover mobile more...